Aug 17, 2013, 02.28 PM IST Samrat Pharmachem has reported a standalone sales turnover of Rs 18.80 crore and a net loss of Rs 0.34 crore for the quarter ended Jun '13 Like this story, share it with millions of investors on M3 Samrat Pharma standalone Jun '13 sales at Rs 18.80 crore Samrat Pharmachem has reported a standalone sales turnover of Rs 18.80 crore and a net loss of Rs 0.34 crore for the quarter ended Jun '13 Like this story, share it with millions of investors on M3 Samrat Pharma standalone Jun '13 sales at Rs 18.80 crore Samrat Pharmachem has reported a standalone sales turnover of Rs 18.80 crore and a net loss of Rs 0.34 crore for the quarter ended Jun '13 Share . Email . Print . A+A- Samrat Pharmachem has reported a standalone sales turnover of Rs 18.80 crore and a net loss of Rs 0.34 crore for the quarter ended Jun '13. Other income for the quarter was Rs 0.02 crore.
| For the quarter ended Jun 2012 the standalone sales turnover was Rs 17.81 crore and net profit was Rs 0.02 crore, and other income Rs 0.04 crore.
| | Samrat Pharma shares closed at 26.60 on August 14, 2013 (BSE) and has given 4.72% returns over the last 6 months and 5.56% over the last 12 months. |
| | | Samrat Pharmachem | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
| | Jun '13 | Mar '13 | Dec '12 | | | | Sales Turnover | 18.80 | 17.27 | 15.83 | | | | Other Income | 0.02 | 0.26 | -- | | | | Total Income | 18.82 | 17.53 | 15.83 | | | | Total Expenses | 18.86 | 17.26 | 15.48 | | | | Operating Profit | -0.06 | 0.01 | 0.35 | | | | Profit On Sale Of Assets | -- | -- | -- | | | | Profit On Sale Of Investments | -- | -- | -- | | | | Gain/Loss On Foreign Exchange | -- | -- | -- | | | | VRS Adjustment | -- | -- | -- | | | | Other Extraordinary Income/Expenses | -- | -- | -- | | | | Total Extraordinary Income/Expenses | -- | -- | -- | | | | Tax On Extraordinary Items | -- | -- | -- | | | | Net Extra Ordinary Income/Expenses | -- | -- | -- | | | | Gross Profit | -0.04 | 0.27 | 0.35 | | | | Interest | 0.21 | 0.20 | 0.17 | | | | PBDT | -0.25 | 0.07 | 0.17 | | | | Depreciation | 0.08 | 0.06 | 0.06 | | | | Depreciation On Revaluation Of Assets | -- | -- | -- | | | | PBT | -0.33 | 0.01 | 0.11 | | | | Tax | 0.01 | 0.01 | 0.02 | | | | Net Profit | -0.34 | -- | 0.09 | | | | Prior Years Income/Expenses | -- | -- | -- | | | | Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | | | | Dividend | -- | -- | -- | | | | Dividend Tax | -- | -- | -- | | | | Dividend (%) | -- | -- | -- | | | | Earnings Per Share | -- | -- | 0.29 | | | | Book Value | -- | -- | -- | | | | Equity | 3.09 | 3.09 | 3.09 | | | | Reserves | 9.47 | -- | 9.79 | | | | Face Value | 10.00 | 10.00 | 10.00 | | | | Source : Dion Global Solutions Limited |
|
| Action in Samrat Pharmachem |
Anda sedang membaca artikel tentang
Samrat Pharma standalone Jun '13 sales at Rs 18.80 crore
Dengan url
http://sehatgayahidup.blogspot.com/2013/08/samrat-pharma-standalone-jun-13-sales.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Samrat Pharma standalone Jun '13 sales at Rs 18.80 crore
namun jangan lupa untuk meletakkan link
Samrat Pharma standalone Jun '13 sales at Rs 18.80 crore
sebagai sumbernya
Related Posts on
0 komentar:
Posting Komentar